“We have been very aggressive,” Dreyzehner said. “We intend to keep close tabs on these people. . . . It’s important for people to realize that the period of exposure is over, but the period of risk [to develop meningitis] is not yet over. It will be some time before it is.”
He said all remaining vials of the steroid have been removed, and sequestered, from health facilities across the state. US health officials are still investigating the cause of the outbreak, Dreyzehner said.
He said the agency contacted the Massachusetts Department of Public Health shortly after it identified the problem steroid treatment. “We’ve enjoyed a positive, close working relationship with Massachusetts officials,” Dreyzehner said.
Massachusetts public health officials Monday said they would continue a vigorous review of the Framingham drug maker.
US Representative Edward J. Markey, a Democrat whose district includes Framingham, sent a letter to the FDA requesting a review of oversight and practices at compounding pharmacies, to ensure safety standards are met, according to a release from his office.